FENNEC PHARMACEUTICALS INC's ticker is FENC and the CUSIP is 31447P100. A total of 55 filers reported holding FENNEC PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is 0.27 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $8,584,673 | -9.5% | 1,143,099 | +6.4% | 4.70% | +11.0% |
| Q2 2023 | $9,489,195 | -8.8% | 1,074,654 | -14.0% | 4.23% | -27.6% |
| Q1 2023 | $10,400,799 | +6.0% | 1,250,096 | +22.3% | 5.85% | +3.3% |
| Q4 2022 | $9,810,739 | +20.5% | 1,021,952 | +1.7% | 5.66% | +58.1% |
| Q3 2022 | $8,141,000 | +19.0% | 1,005,101 | -17.0% | 3.58% | +45.7% |
| Q2 2022 | $6,840,000 | +0.9% | 1,210,638 | 0.0% | 2.46% | +81.1% |
| Q1 2022 | $6,780,000 | +32.9% | 1,210,638 | +4.4% | 1.36% | +61.9% |
| Q4 2021 | $5,101,000 | -12.4% | 1,159,389 | +87.5% | 0.84% | -29.1% |
| Q3 2021 | $5,826,000 | +35.7% | 618,451 | +5.0% | 1.18% | +27.6% |
| Q2 2021 | $4,292,000 | – | 588,773 | – | 0.93% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sonic GP LLC | 2,407,357 | $18,079,251 | 17.55% |
| Solas Capital Management, LLC | 1,725,567 | $12,959,008 | 9.07% |
| DG Capital Management, LLC | 1,143,099 | $8,584,673 | 4.70% |
| HARBERT FUND ADVISORS, INC. | 466,869 | $3,506,186 | 2.56% |
| AIGH Capital Management LLC | 373,526 | $2,805,180 | 1.33% |
| Southpoint Capital Advisors LP | 4,077,214 | $30,619,877 | 0.68% |
| APIS CAPITAL ADVISORS, LLC | 70,000 | $525,700 | 0.68% |
| Worth Venture Partners, LLC | 92,636 | $695,696 | 0.41% |
| Lion Point Capital, LP | 110,000 | $826,100 | 0.37% |
| 683 Capital Management, LLC | 300,000 | $2,253,000 | 0.18% |